Text size Decrease text size Increase text size

For Patients

Accu-Chek.co.uk offers patient-focused product information on our portfolio of meters, insulin pumps, data management, and structured testing tools. Please follow the link below for more information.

Visit Accu-Chek.co.uk

Under 18?

This website for under 18's from Roche Diabetes Care contains some great interactive tools to help you and your family learn more about diabetes and encourage you to get more involved.

Accu-Chek Kids

Share this page Email This Page Print this page

Close X

Email This Page

All fields must be filled in

Advice: To send to multiple e-mail addresses, separate email addresses with a comma

See Beyond HbA1c

 What are you missing with HbA1c?

Look beyond average blood glucose measurements.

Haemoglobin A1c (HbA1c) has been considered the clinical standard to determine overall glycaemic control. Although valuable as a long-term glycaemic measure, HbA1c does not expose day-to-day and intra-day blood glucose fluctuations.18

HbA1c is a valuable measurement for long-term glycaemic control but does not reveal acute glycaemic variations.

By measuring the percentage of the glycated haemoglobin molecule, HbA1c reveals the level of exposure to blood glucose over the last 2 to 3 months; the greater the exposure, the higher the HbA1c result.16 Reviewing a succession of HbA1c results provides an assessment of a patient’s overall long term glucose exposure. However, HbA1c does not provide information about short-term glucose exposure, glucose variability, episodes of low or high glucose or the risks of acute hypoglycaemia.

Two patients with the same HbA1c can experience different glycaemic swings and may require significantly different treatment approaches.

SMBG reveals critical problems in glycaemic exposure that influence therapy decisions.

Self-monitoring of blood glucose (SMBG) should be incorporated as an important adjunct to HbA1c measurements, offering identification of hypoglycaemic episodes, a distinction between fasting, pre-prandial and postprandial hyperglycaemia and information on glycaemic excursions.

The clinical relevance of identifying and treating hypoglycaemia, postprandial hyperglycaemia and glycaemic variability becomes increasingly significant as studies expose the correlation between unresolved or escalating glycaemic abnormalities and diabetes-related diseases.

What you won’t see with HbA1c…


Clinical evidence

For articles and studies regarding glycaemic abnormalities, including counter-arguments, visit Clinical Evidence.

16 Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM. Tests of glycemia in diabetes. Diabetes Care. 2003; 26(Suppl 1): S106-S108.
18 Dailey G. Assessing glycaemic control with self-monitoring of blood glucose and haemoglobin A1c measurements. Mayo Clin Proc. 2007; 82(2): 229-236.

the glycaemic pattern assessment revealed by an identification of blood glucose results above or below the target range

low blood glucose

short-term measure of diabetes control; assesses the degree to which blood glucose levels fluctuate from high to low

high blood glucose following a meal

long-term measure of diabetes control; assesses average level of glucose exposure over a 2 to 3 month period

at-home blood glucose testing conducted by people with diabetes, typically with a blood glucose meter


Download the IDF Guideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes

Discover your patients’ blood glucose patterns

Provide a tailored treatment.

Performing pattern analysis on structured blood glucose measurements reveals actionable results.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.